About this product
Derived from the “Durga Mata” phenotype, DM2 by Zenabis is a high CBD, low THC indica-dominant strain for medical cannabis patients. This dried flower has aromatic, dark green buds, a minty, earthy aroma and sweet, orange and citrus notes.
Indicas like DM2 are often associated with sedating effects like relaxation, pain reduction, decreased nausea, and increased appetite. CBD is a non-intoxicating chemical compound believed to alleviate pain, inflammation, and anxiety.
CANNABINOIDS
THC: 9-13%
CBD: 4-8%
TERPENES
limonene, terpinolene, myrcene
ZENABIS
Zenabis is a licensed producer of medical and recreational cannabis products. With Health Canada licensed facilities in British Columbia, New Brunswick, and Nova Scotia, our high-quality products are grown with patients’ health and safety in mind. Our diverse team of doctors, scientists, researchers, growers, educators and advocates came together with the goal of increasing access to safe, high-quality cannabis for medical patients and recreational consumers.
Indicas like DM2 are often associated with sedating effects like relaxation, pain reduction, decreased nausea, and increased appetite. CBD is a non-intoxicating chemical compound believed to alleviate pain, inflammation, and anxiety.
CANNABINOIDS
THC: 9-13%
CBD: 4-8%
TERPENES
limonene, terpinolene, myrcene
ZENABIS
Zenabis is a licensed producer of medical and recreational cannabis products. With Health Canada licensed facilities in British Columbia, New Brunswick, and Nova Scotia, our high-quality products are grown with patients’ health and safety in mind. Our diverse team of doctors, scientists, researchers, growers, educators and advocates came together with the goal of increasing access to safe, high-quality cannabis for medical patients and recreational consumers.
We couldn’t find this item at any stores nearby. Check back later or view similar products.
view similar productsAbout this product
Derived from the “Durga Mata” phenotype, DM2 by Zenabis is a high CBD, low THC indica-dominant strain for medical cannabis patients. This dried flower has aromatic, dark green buds, a minty, earthy aroma and sweet, orange and citrus notes.
Indicas like DM2 are often associated with sedating effects like relaxation, pain reduction, decreased nausea, and increased appetite. CBD is a non-intoxicating chemical compound believed to alleviate pain, inflammation, and anxiety.
CANNABINOIDS
THC: 9-13%
CBD: 4-8%
TERPENES
limonene, terpinolene, myrcene
ZENABIS
Zenabis is a licensed producer of medical and recreational cannabis products. With Health Canada licensed facilities in British Columbia, New Brunswick, and Nova Scotia, our high-quality products are grown with patients’ health and safety in mind. Our diverse team of doctors, scientists, researchers, growers, educators and advocates came together with the goal of increasing access to safe, high-quality cannabis for medical patients and recreational consumers.
Indicas like DM2 are often associated with sedating effects like relaxation, pain reduction, decreased nausea, and increased appetite. CBD is a non-intoxicating chemical compound believed to alleviate pain, inflammation, and anxiety.
CANNABINOIDS
THC: 9-13%
CBD: 4-8%
TERPENES
limonene, terpinolene, myrcene
ZENABIS
Zenabis is a licensed producer of medical and recreational cannabis products. With Health Canada licensed facilities in British Columbia, New Brunswick, and Nova Scotia, our high-quality products are grown with patients’ health and safety in mind. Our diverse team of doctors, scientists, researchers, growers, educators and advocates came together with the goal of increasing access to safe, high-quality cannabis for medical patients and recreational consumers.
No product reviews
Have you tried this product? Be the first to leave a review!
About this brand
Zenabis
We are a diverse, passionate team of doctors, scientists, researchers, growers, educators, and advocates who came together with the goal of increasing access to safe, high quality cannabis for medical patients and recreational consumers. Our four facilities are located coast-to-coast across Canada in Delta and Langley, British Columbia; Atholville, New Brunswick; and Stellarton, Nova Scotia. Zenabis currently owns 3.5 million square feet of facility space that can, upon full conversion, be dedicated to cannabis production.
Notice a problem?Report this item